Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Nichols

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Blood|January 17, 2012
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogsJennifer A Dumont, Tongyao Liu, Susan C Low, et al.
Blood|March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia BValder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Journal of Vascular Surgery|July 17, 2017
Performance of acoustic radiation force impulse ultrasound imaging for carotid plaque characterization with histologic validationTomasz J Czernuszewicz, Jonathon W Homeister, Melissa C Caughey, et al.
Nature Communications|November 21, 2013
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia ALily M Du, Paquita Nurden, Alan T Nurden, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic riskJanka Mátrai, Alessio Cantore, Cynthia C Bartholomae, et al.
Blood|June 25, 2011
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptideHenrik Østergaard, Jais R Bjelke, Lene Hansen, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
The Lancet. Haematology|June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trialMargaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Blood|January 17, 2012
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogsJennifer A Dumont, Tongyao Liu, Susan C Low, et al.
Blood|March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia BValder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Journal of Vascular Surgery|July 17, 2017
Performance of acoustic radiation force impulse ultrasound imaging for carotid plaque characterization with histologic validationTomasz J Czernuszewicz, Jonathon W Homeister, Melissa C Caughey, et al.
Nature Communications|November 21, 2013
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia ALily M Du, Paquita Nurden, Alan T Nurden, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic riskJanka Mátrai, Alessio Cantore, Cynthia C Bartholomae, et al.
Blood|June 25, 2011
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptideHenrik Østergaard, Jais R Bjelke, Lene Hansen, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
The Lancet. Haematology|June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trialMargaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
Pageof 11